26.36Open26.36Pre Close0 Volume13 Open Interest57.00Strike Price0.00Turnover0.00%IV-13.52%PremiumNov 15, 2024Expiry Date30.01Intrinsic Value100Multiplier0DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma1.02Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Trump Media & Technology Stock Discussion
Hugely Undervalued $2 Biotech With 21% Held Short $16 Price Target, Takeover Candidate, Soon Profitable. Fund that owns $Viking Therapeutics (VKTX.US)$ since 2022 below $10 a share is also investing in ESPR and expects the company will be a block buster.
This unique biotech $Esperion Therapeutics (ESPR.US)$ Esper...
but ya premarket used to be in millions or at least a few hundred ks
I'm just afraid if this delists he starts fighting with nasdaq causing a black swan ppl will defend him regardless
No comment yet